Drug Information Association Logo

Who Benefits Most from Androgen Deprivation Therapy Among Newly Diagnosed Elderly Metastatic Prostate Cancer Patients?

Time

Mon, Jun 16 7:45AM
M 17

Title

Who Benefits Most from Androgen Deprivation Therapy Among Newly Diagnosed Elderly Metastatic Prostate Cancer Patients?

Abstract Summary

We analyzed elderly men diagnosed with mPC between 2000-2009 in the SEER-Medicare datasets and followed through 2010 or until loss to follow-up. An inverse probability weighted Cox proportional hazards model was used to estimate the hazard of progression, dying from prostate cancer or other causes.

Poster Presenter

Abdalla Aly
Graduate Research Assistant,
University of Maryland School of Pharmacy
United States